-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$44.0067.11% Upside
Evolent Health, Inc. Frequently Asked Questions
-
What analysts cover Evolent Health, Inc.?
Evolent Health, Inc. has been rated by research analysts at Truist Financial, RBC Capital, Piper Sandler, Canaccord Genuity, BTIG in the past 90 days.